NCM · Medical - Care Facilities

Starling Oncology, Inc. (STLN) Stock

$6.72 +8.66% NCM: STLN Healthcare

Valuation

MetricValue
Price$6.72
Market Cap$671.39M
P/E Ratio-20.83
P/B Ratio-25.85
P/S Ratio1.06
EPS (TTM)$-0.54
52-Week High$7.13
52-Week Low$2.32
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE209.81%
ROA-20.36%
ROCE-31.32%
Gross Margin-7.16%
Operating Margin-7.16%
Net Margin-6.18%
Debt/Equity-4.19
Current Ratio1.59

Annual Financials (USD)

Metric20212022202320242025
Revenue$203.0M$252.0M$324.0M$393.0M$503.0M
Operating Profit$-46.0M$-82.0M$-77.0M$-60.0M$-36.0M
Net Profit$-11.0M$0$-83.0M$-65.0M$-61.0M
EPS$-0.16$-0.21$-0.92$-0.71$-0.54
Op Margin-23.0%-32.0%-24.0%-15.0%-7.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$203.0M$262.0M$209.0M$173.0M$165.0M
Total Liabilities$99.0M$138.0M$152.0M$169.0M$180.0M
Cash$1.0M$1.0M$1.0M$1.0M$1.0M
Borrowings$0$81.0M$87.0M$93.0M$78.0M

Latest News

Oncology Institute Q2 Earnings Call Highlights MarketBeat · Aug 7, 2026 The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates Zacks · Aug 6, 2026 Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance GlobeNewswire · Aug 6, 2026 Earnings To Watch: Starling Oncology Inc (STLN) Q2 2026 -- GF Value Sees 44% Downside GuruFocus.com · Aug 5, 2026 The Oncology Institute Changes Name to Starling Oncology MT Newswires · Aug 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-33.0M$-62.0M$-36.0M$-27.0M$-25.0M
Investing Cash Flow$-12.0M$-132.0M$63.0M$46.0M$-3.0M
Financing Cash Flow$154.0M$92.0M$-7.0M$-3.0M$12.0M
Net Cash Flow$109.0M$-101.0M$19.0M$16.0M$-16.0M
Free Cash Flow$-36.0M$-67.0M$-41.0M$-30.0M$-28.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.31
EV / EBITDA-31.49
FCF Yield-0.53%
Quick Ratio1.15
Interest Coverage-3.42
Return 1Y46.11%
Return 3Y538.66%
Return 5Y-37.61%

Ownership

Insiders Held18.07%
Institutions Held46.46%
Institutions Float Held56.70%
Institutional HolderSharesReport Date
Blackrock Inc.4,415,8672026-03-31
Vanguard Capital Management LLC3,476,7812026-03-31
Deerfield Management Company, L.P3,360,0522026-03-31
Kanen Wealth Management LLC2,777,8582026-03-31
Josh Arnold Investment Consultant, Llc2,464,3592026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $337.49 -0.86% 38.93 $4.96T 0.32%
MSFTMicrosoft Corporation $537.04 +2.76% 28.68 $3.99T 0.76%
GOOGLAlphabet Inc. $351.55 +0.93% 16.94 $4.25T 0.26%
AMZNAmazon.com, Inc. $261.46 +2.91% 19.82 $2.81T 0.00%
METAMeta Platforms, Inc. $718.82 -0.29% 27.93 $1.83T 0.28%

About Starling Oncology, Inc.

Starling Oncology, Inc. is headquartered in US.

Starling Oncology, Inc. (STLN) stock trades at $6.72 with a market capitalization of $671.39M. The stock is valued at a price-to-earnings (P/E) ratio of -20.83, price-to-book of -25.85, price-to-sales of 1.06. Over the past 52 weeks the stock has ranged between $2.32 and $7.13, and currently trades 5.8% below its 52-week high.

On profitability, Starling Oncology, Inc. generates a return on equity (ROE) of 209.81% — well above the market average, a sign of a high-quality business, return on capital employed of -31.32%, an operating margin of -7.16%, a net profit margin of -6.18%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1175.60 +0.51% JNJ Johnson & Johnson $259.92 +1.34% ABBV AbbVie Inc. $276.17 +1.38% MRK Merck & Company, Inc. Common Stock (new) $146.13 +2.63% UNH UnitedHealth Group Incorporated Common Stock (DE) $382.39 +3.08% NVS Novartis AG $143.79 +0.47% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $659.63 +1.17% AMGN Amgen Inc. $417.07 +2.36% GILD Gilead Sciences, Inc. $150.92 +2.60% ABT Abbott Laboratories $99.12 +0.64% NVO Novo Nordisk A/S $38.42 +0.62%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides